USP-795 is the United States Pharmacopeia standard for non-sterile compounding — things like creams, capsules, and oral suspensions. It covers cleanliness, ingredient quality, and labeling, but does not require a sterile environment.

USP-797 is the stricter standard for sterile compounding, including injectables. It requires a certified clean room, air-flow controls, sterility testing, and trained personnel. Injectable peptides fall under this standard.

Compounding pharmacy quality: the difference between USP-795 and USP-797

Creator: Halftime Health
Keywords: USP-795 vs USP-797, compounding pharmacy quality, sterile compounding standards, compounding pharmacy quality standards

Two standards run the back of a compounding pharmacy. One is for ointments. The other is for needles. Here is how they actually differ.

TL;DR

USP-795 covers non-sterile compounding — creams, capsules, suspensions you take by mouth or apply to the skin.
USP-797 covers sterile compounding — anything injected, including peptide preparations.
Injectable peptides require USP-797 compliance. A pharmacy that only meets USP-795 should not be filling sterile peptide orders.

What it is

USP (in plain English: the United States Pharmacopeia, a non-government group that writes drug quality standards) publishes the rulebooks compounding pharmacies follow. Two of those rulebooks matter most: USP-795 and USP-797. Think of them like building codes. USP-795 is the code for a kitchen — clean, organized, careful with ingredients. USP-797 is the code for a surgical room — air-flow controls, certified clean rooms, sterility testing of every batch. Both protect the patient. They protect against different risks.

How it works

USP-795 sets rules for non-sterile compounded preparations: a topical cream a compounder mixes for a patient, an oral capsule with a custom dose. The pharmacy still has to source quality ingredients, document the formula, and label correctly. USP-797 is built for anything that bypasses the gut and goes directly into the body. A clean room is required. Air filters control particles. Staff gown up. Each batch undergoes sterility and endotoxin testing per the US Pharmacopeia compounding standards. The stakes are higher because skin is the body’s main barrier — and an injection bypasses it.

Who asks about it

People come to this topic when they hear “compounded peptide” and want to know what stands behind the vial. The honest answer is: a set of standards, and the question of whether the specific pharmacy actually follows them.

What the research says

Peer-reviewed pharmacy and safety literature consistently finds that adverse events from compounded injectables track closely with USP-797 compliance gaps — contamination, improper beyond-use dating, or non-sterile preparation rooms. The FDA’s compounding pages document past inspections where 503A pharmacies that failed USP-797 audits had to recall sterile products. The standards work when followed. The risk is that following them is not automatic.

What to know before considering it

Patients can ask their compounding pharmacy two questions: which USP chapters do you follow, and do you publish your certificates of compliance. A pharmacy that cannot answer either question is a flag. Compounded peptides are not FDA-approved. The licensed clinician prescribing them should know the pharmacy’s quality record.

The Halftime POV

We remove the mystery by translating quality codes into kitchen-table language. USP-795 is the rule for things that go on you. USP-797 is the rule for things that go in you. Knowing which one applies tells you a lot about the questions worth asking before any peptide order is filled.

Related reading:

FAQ

Q: What is USP-795? A: USP-795 is the US Pharmacopeia standard for non-sterile compounding — creams, capsules, oral suspensions. It does not require a sterile environment.

Q: What is USP-797? A: USP-797 is the stricter standard for sterile compounding, including injectables. It requires a certified clean room, air controls, sterility testing, and trained personnel.

Q: Should my peptide pharmacy follow USP-797? A: Yes, if the peptide is injectable. USP-797 compliance is the floor, not the ceiling, for a 503A handling sterile peptide preparations.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. Join the waitlist for updates.

Sources

US Pharmacopeia. Compounding standards (USP-795, USP-797). https://www.usp.org/compounding
US Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
National Center for Biotechnology Information. Compounding pharmacy quality overview. https://www.ncbi.nlm.nih.gov/books/NBK542203/